Skip to main content

Merck MK-5172-017-02 A long-term follow-up study to evaluate the durability of Viro-Logic response and/or viral resistance patterns of subjects with Chronic Hepatitis C who have been previously treated with MK-5172 in a prior clinical trial.

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Gastroenterology

Awarded By

Merck Sharp & Dohme

Start Date

February 1, 2015

End Date

November 10, 2017
 

Administered By

Medicine, Gastroenterology

Awarded By

Merck Sharp & Dohme

Start Date

February 1, 2015

End Date

November 10, 2017